ATE135217T1 - Pharmazeutische zusammensetzungen zur aids- behandlung - Google Patents

Pharmazeutische zusammensetzungen zur aids- behandlung

Info

Publication number: ATE135217T1
Authority: AT; Austria
Prior art keywords: image; pharmaceutical compositions; bri; aids treatment; aliphatic
Prior art date: 1990-09-04

Application number

AT91917237T

Other languages

English (en)

Inventor

Stanislaw R Burzynski

Original Assignee

Stanislaw R Burzynski

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-04

Filing date

1991-08-21

Publication date

1996-03-15

1991-08-21 Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski

1996-03-15 Application granted granted Critical

1996-03-15 Publication of ATE135217T1 publication Critical patent/ATE135217T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 3
208000030507 AIDS Diseases 0.000 title 1
WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical class OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 abstract 2
208000012124 AIDS-related disease Diseases 0.000 abstract 1
125000001931 aliphatic group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229960003424 phenylacetic acid Drugs 0.000 abstract 1
239000003279 phenylacetic acid Substances 0.000 abstract 1
150000005458 piperidinediones Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Hydrogenated Pyridines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT91917237T 1990-09-04 1991-08-21 Pharmazeutische zusammensetzungen zur aids- behandlung ATE135217T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/577,464 US5089508A (en)	1990-09-04	1990-09-04	Methods for treating aids

Publications (1)

Publication Number	Publication Date
ATE135217T1 true ATE135217T1 (de)	1996-03-15

Family

ID=24308852

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91917237T ATE135217T1 (de)	1990-09-04	1991-08-21	Pharmazeutische zusammensetzungen zur aids- behandlung

Country Status (11)

Country	Link
US (1)	US5089508A (de)
EP (1)	EP0500905B1 (de)
AT (1)	ATE135217T1 (de)
AU (1)	AU638869B2 (de)
DE (1)	DE69117923T2 (de)
DK (1)	DK0500905T3 (de)
ES (1)	ES2084181T3 (de)
GR (1)	GR3019970T3 (de)
SG (1)	SG81889A1 (de)
WO (1)	WO1992004027A1 (de)
ZA (1)	ZA916977B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5244922A (en) *	1990-09-04	1993-09-14	Burzynski Stanislaw R	Methods for treating viral infections
EP0527241B1 (de) *	1991-07-15	1994-03-16	Artesan Pharma Gesellschaft mit beschränkter Haftung	Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich
US5646182A (en) *	1992-06-15	1997-07-08	Burzynski; Stanislaw R.	Methods for treating autoimmune diseases
DE4320201A1 (de) *	1993-06-18	1995-01-12	Asta Medica Ag	Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation
ATE310505T1 (de) *	1996-05-14	2005-12-15	Stanislaw R Burzynski	Liposomale antineoplaston therapie mit bemerkenswert verbesserter antineoplastischer aktivität
US6127419A (en) *	1998-11-23	2000-10-03	Burzynski; Stanislaw R.	Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4470970A (en) *	1981-07-02	1984-09-11	Burzynski Stanislaw R	Purified antineoplaston fractions and methods of treating neoplastic disease
US4558057A (en) *	1981-12-15	1985-12-10	Burzynski Stanislaw R	Purified antineoplaston fractions and methods of treating neoplastic disease
US4427684A (en) *	1982-09-24	1984-01-24	Ores Richard O	Treatment and prevention of infection with herpes simplex and related viruses
DE3686622T2 (de) *	1985-09-11	1993-04-01	British Tech Group	Verwendung von dioxopiperidin-derivaten zur behandlung von anxietas, zur herabsetzung von chronischen abnormal hohen gehirn-spiegeln serotonins oder 5-hydroxy-indolessigsaeure und zur behandlung von bakteriellen oder viralen infektionen.
US4705796A (en) *	1986-08-25	1987-11-10	Stereochemical Genetics, Inc.	Use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorders
DE3814549A1 (de) *	1987-10-30	1989-05-18	Bayer Ag	N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln

1990
- 1990-09-04 US US07/577,464 patent/US5089508A/en not_active Expired - Lifetime
1991
- 1991-08-21 AT AT91917237T patent/ATE135217T1/de not_active IP Right Cessation
- 1991-08-21 SG SG9607278A patent/SG81889A1/en unknown
- 1991-08-21 WO PCT/US1991/005977 patent/WO1992004027A1/en not_active Ceased
- 1991-08-21 ES ES91917237T patent/ES2084181T3/es not_active Expired - Lifetime
- 1991-08-21 DE DE69117923T patent/DE69117923T2/de not_active Expired - Fee Related
- 1991-08-21 AU AU85397/91A patent/AU638869B2/en not_active Ceased
- 1991-08-21 EP EP91917237A patent/EP0500905B1/de not_active Expired - Lifetime
- 1991-08-21 DK DK91917237.9T patent/DK0500905T3/da active
- 1991-09-03 ZA ZA916977A patent/ZA916977B/xx unknown
1996
- 1996-05-20 GR GR960401345T patent/GR3019970T3/el unknown

Also Published As

Publication number	Publication date
WO1992004027A1 (en)	1992-03-19
AU638869B2 (en)	1993-07-08
DE69117923T2 (de)	1996-08-01
DE69117923D1 (de)	1996-04-18
ES2084181T3 (es)	1996-05-01
AU8539791A (en)	1992-03-30
EP0500905B1 (de)	1996-03-13
GR3019970T3 (en)	1996-08-31
SG81889A1 (en)	2001-07-24
EP0500905A1 (de)	1992-09-02
ZA916977B (en)	1992-06-24
US5089508A (en)	1992-02-18
DK0500905T3 (da)	1996-08-05

Similar Documents

Publication	Publication Date	Title
DE69625906D1 (de)	2003-02-27	Dinukleotide zur verwendung in der behandlung von lungenkrankheiten
ES2165969T3 (es)	2002-04-01	Compuestos nitrogenados aromaticos condensados 5,5 aril-sustituidos como agentes antiinflamatorios.
SE8601103D0 (sv)	1986-03-10	Neue, schwefelhaltige 5-substituierte benzimidazol-derivate und verfahren zu ihrer herstellung
DE69327642D1 (de)	2000-02-24	Verfahren zur behandlung von viralen infectionen
DE69727956D1 (de)	2004-04-08	Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
ES2141957T3 (es)	2000-04-01	Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
ATE137753T1 (de)	1996-05-15	Codeinsalz einer substituierten carbonsäure, verfahren zu seiner herstellung, seine verwendung und pharmazeutische präparate
PT100415A (pt)	1993-06-30	Novas morfolinas de accao farmaceutica, e processo para a sua preparacao
DE69117923D1 (de)	1996-04-18	Pharmazeutische zusammensetzungen zur aids-behandlung
ES2082882T3 (es)	1996-04-01	Procedimiento para la fabricacion de derivados de acidos-3-amino-2-(het)aroil-acrilicos.
BR9712033A (pt)	2000-01-18	Composição farmacêutica para tratamento de doenças virais.
ATE134363T1 (de)	1996-03-15	N-((4,5-dihydroxy- und 4,5,8-trihydroxy-9,10- dihydro-9,10-dioxo-2-anthracen- yl)carbonyl)aminosäure zur therapie osteoartikulärer leiden
BR9306870A (pt)	1998-12-08	Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
KR930702978A (ko)	1993-11-29	인식력 장애의 치료
DE69316729D1 (de)	1998-03-05	Zusammensetzungen und verfahren zur behandlung von autoimmunkrankheiten
MY133438A (en)	2007-11-30	Morpholinobenzamide salts
ATE37370T1 (de)	1988-10-15	Triazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ES2121071T3 (es)	1998-11-16	Compuestos de oxazolidina y su empleo como medicamentos.
ES2005778A6 (es)	1989-03-16	Procedimiento para la obtencion de derivados de diisobutilxantina.

Legal Events

Date	Code	Title	Description
1996-09-15	UEP	Publication of translation of european patent specification
2010-05-15	REN	Ceased due to non-payment of the annual fee